US Fed Dragged D-Street
Feb 15, 2017 | 18:29 PM IST
Feb 15, 2017 | 18:29 PM IST
Market Walk 15th February, 2016:
Global uncertainty with Federal Reserve policy dragged the market down.
Sensex lost 183.75 points to 28155.56
Nifty lost 67.6 points to 8724.7
Zeel gained 1.61% to 521.2
Among the top gainers were Infratel by 1.33% to 323.0, ITC by 1.22% to 274.1, TCS by 0.71% to 2423.45, HDFC by 0.69% to 1320.1.
Among the top losers were Tata Motors DVR lost 9.86% to 268.4. Tata Motors by 9.41% to 436.7, Sunpharma by 4.2% to 622.0, Aurobindo Pharma by 3.55% to 635.0, Bank of Baroda by 3.47% to 162.95.
Tata Motors shares, which dragged the Nifty Auto index 3 percent, crashed 10.3 percent (in addition to 3.7 percent loss in previous session) as analysts are worried over JLR's hedging losses that are expected to continue for next 3-4 quarters. Tata Motors DVR also dropped 10 percent. CLSA has downgraded Tata Motors to sell and slashed target price to Rs 405 from Rs 650 after cutting FY18-19 EPS estimates by 25-31 percent due to dismal performance in Q3FY17. Management commentary on JLR margins has weakened significantly, it says, adding hedging losses are likely to continue at high levels for longer. Sun Pharma shed 4 percent after earnings missed analysts' expectations. Citi says delay in fresh approvals from Halol plant would remain overhangs while Nomura cut FY17 earnings estimates by 9 percent, FY18 by 5 percent & FY19 by 3 percent.
Stocks to Watch: Gujarat Ambuja Exports Ltd is on up side while Infratel is on down side.
At Niveza India Pvt Ltd., we all come to work everyday to take the challenges of stock market head on and to change people's perception that stock market investment is like a gamble. Over the years, we have built our profile as a company which has brought optimum value to our subscribers through our well-researched stock recommendations.... More>>
Disclaimer: Niveza does not guarantee the accuracy or completeness of information on the site, nor does Niveza assume any liability for any loss that may result from reliance upon any such information or recommendations. Information and recommendations on the site are for general information only. Nothing contained herein is an offer to sell nor solicitation to buy any securities.